nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—TACR1—trigeminal nerve—multiple sclerosis	0.128	0.433	CbGeAlD
Fosaprepitant—TACR1—peripheral nervous system—multiple sclerosis	0.0601	0.203	CbGeAlD
Fosaprepitant—TACR1—nerve—multiple sclerosis	0.0469	0.158	CbGeAlD
Fosaprepitant—TACR1—brainstem—multiple sclerosis	0.0201	0.0678	CbGeAlD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.0134	0.0643	CbGpPWpGaD
Fosaprepitant—TACR1—spinal cord—multiple sclerosis	0.0125	0.0422	CbGeAlD
Fosaprepitant—TACR1—nervous system—multiple sclerosis	0.0105	0.0355	CbGeAlD
Fosaprepitant—TACR1—central nervous system—multiple sclerosis	0.0102	0.0342	CbGeAlD
Fosaprepitant—TACR1—Peptide GPCRs—CCR1—multiple sclerosis	0.00821	0.0395	CbGpPWpGaD
Fosaprepitant—TACR1—brain—multiple sclerosis	0.00806	0.0272	CbGeAlD
Fosaprepitant—TACR1—Spinal Cord Injury—MBP—multiple sclerosis	0.00693	0.0334	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.00554	0.0267	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide GPCRs—CXCR3—multiple sclerosis	0.00544	0.0262	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide GPCRs—CCR2—multiple sclerosis	0.00529	0.0255	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—AQP4—multiple sclerosis	0.00525	0.0253	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—GPR65—multiple sclerosis	0.00427	0.0206	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.0042	0.0202	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCR1—multiple sclerosis	0.00386	0.0186	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CXCL13—multiple sclerosis	0.00386	0.0186	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.00382	0.0184	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—CCR2—multiple sclerosis	0.00364	0.0175	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.00351	0.0169	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide GPCRs—CCR5—multiple sclerosis	0.00341	0.0164	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—CXCL10—multiple sclerosis	0.00303	0.0146	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.00283	0.0136	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCL3—multiple sclerosis	0.00275	0.0133	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—BDNF—multiple sclerosis	0.00272	0.0131	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—S1PR1—multiple sclerosis	0.00267	0.0129	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00259	0.0125	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00259	0.0125	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CXCR3—multiple sclerosis	0.00256	0.0123	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL4—multiple sclerosis	0.00252	0.0122	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCR2—multiple sclerosis	0.00249	0.012	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.00217	0.0105	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—GPR65—multiple sclerosis	0.00216	0.0104	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—TLR4—multiple sclerosis	0.00209	0.0101	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.00208	0.01	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CXCL10—multiple sclerosis	0.00207	0.00996	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—ICAM1—multiple sclerosis	0.002	0.00966	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCR1—multiple sclerosis	0.00197	0.0095	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CXCL13—multiple sclerosis	0.00197	0.0095	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00184	0.00889	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—CCL2—multiple sclerosis	0.00179	0.00865	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCL5—multiple sclerosis	0.00178	0.00857	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00178	0.00856	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00172	0.00826	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00167	0.00804	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCR5—multiple sclerosis	0.0016	0.00772	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00154	0.00742	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IFNG—multiple sclerosis	0.00153	0.00735	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00151	0.00728	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL3—multiple sclerosis	0.0014	0.00677	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00139	0.00668	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—S1PR1—multiple sclerosis	0.00137	0.00661	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL1B—multiple sclerosis	0.00136	0.00656	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL2—multiple sclerosis	0.00136	0.00653	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—PTGER4—multiple sclerosis	0.00135	0.00652	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CXCR3—multiple sclerosis	0.00131	0.00629	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—RGS1—multiple sclerosis	0.00129	0.00619	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—MMP9—multiple sclerosis	0.00128	0.00618	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCR2—multiple sclerosis	0.00127	0.00612	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.00125	0.00604	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.00123	0.00591	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—GPR65—multiple sclerosis	0.00122	0.00587	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00119	0.00575	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CNR1—multiple sclerosis	0.00117	0.00565	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—RGS1—multiple sclerosis	0.00117	0.00562	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR1—multiple sclerosis	0.00111	0.00537	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00111	0.00537	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—GPR65—multiple sclerosis	0.00111	0.00533	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.00109	0.00524	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00108	0.00518	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—LINGO1—multiple sclerosis	0.00107	0.00515	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—MYC—multiple sclerosis	0.00106	0.00511	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—TGFB1—multiple sclerosis	0.00106	0.0051	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CXCL10—multiple sclerosis	0.00106	0.00509	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—MAPK1—multiple sclerosis	0.00104	0.005	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL13—multiple sclerosis	0.00101	0.00488	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCR1—multiple sclerosis	0.00101	0.00488	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.00101	0.00486	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—TNF—multiple sclerosis	0.000987	0.00476	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TAGAP—multiple sclerosis	0.000928	0.00447	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL5—multiple sclerosis	0.000909	0.00438	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00084	0.00405	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000822	0.00396	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCR5—multiple sclerosis	0.000819	0.00394	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—S1PR1—multiple sclerosis	0.000811	0.00391	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL6—multiple sclerosis	0.000797	0.00384	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.00079	0.00381	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GPC5—multiple sclerosis	0.000789	0.0038	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000764	0.00368	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000738	0.00356	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCL3—multiple sclerosis	0.000721	0.00347	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000718	0.00346	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000694	0.00334	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—RGS1—multiple sclerosis	0.000689	0.00332	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CXCR3—multiple sclerosis	0.00067	0.00323	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000663	0.00319	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GPR65—multiple sclerosis	0.000654	0.00315	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCR2—multiple sclerosis	0.000652	0.00314	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000642	0.00309	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—POMC—multiple sclerosis	0.00064	0.00308	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000637	0.00307	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL2—multiple sclerosis	0.000626	0.00302	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CNR1—multiple sclerosis	0.000602	0.0029	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCL13—multiple sclerosis	0.000598	0.00288	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCR1—multiple sclerosis	0.000598	0.00288	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000597	0.00287	CbGpPWpGaD
Fosaprepitant—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000564	0.00114	CcSEcCtD
Fosaprepitant—Hypertension—Triamcinolone—multiple sclerosis	0.000563	0.00114	CcSEcCtD
Fosaprepitant—Hypertension—Methylprednisolone—multiple sclerosis	0.000562	0.00113	CcSEcCtD
Fosaprepitant—Urticaria—Mitoxantrone—multiple sclerosis	0.00056	0.00113	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00056	0.00113	CcSEcCtD
Fosaprepitant—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000558	0.00113	CcSEcCtD
Fosaprepitant—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000558	0.00113	CcSEcCtD
Fosaprepitant—Vomiting—Azathioprine—multiple sclerosis	0.000555	0.00112	CcSEcCtD
Fosaprepitant—Eye disorder—Prednisone—multiple sclerosis	0.000553	0.00112	CcSEcCtD
Fosaprepitant—Anxiety—Methylprednisolone—multiple sclerosis	0.000552	0.00111	CcSEcCtD
Fosaprepitant—Infestation—Methotrexate—multiple sclerosis	0.000551	0.00111	CcSEcCtD
Fosaprepitant—Infestation NOS—Methotrexate—multiple sclerosis	0.000551	0.00111	CcSEcCtD
Fosaprepitant—Rash—Azathioprine—multiple sclerosis	0.00055	0.00111	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00055	0.00111	CcSEcCtD
Fosaprepitant—Dermatitis—Azathioprine—multiple sclerosis	0.00055	0.00111	CcSEcCtD
Fosaprepitant—Flushing—Prednisone—multiple sclerosis	0.000549	0.00111	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000549	0.00111	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000549	0.00111	CcSEcCtD
Fosaprepitant—Discomfort—Triamcinolone—multiple sclerosis	0.000549	0.00111	CcSEcCtD
Fosaprepitant—Discomfort—Methylprednisolone—multiple sclerosis	0.000547	0.0011	CcSEcCtD
Fosaprepitant—Headache—Azathioprine—multiple sclerosis	0.000547	0.0011	CcSEcCtD
Fosaprepitant—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000546	0.0011	CcSEcCtD
Fosaprepitant—Dry mouth—Triamcinolone—multiple sclerosis	0.000543	0.0011	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000542	0.00261	CbGpPWpGaD
Fosaprepitant—Angioedema—Betamethasone—multiple sclerosis	0.000541	0.00109	CcSEcCtD
Fosaprepitant—Angioedema—Dexamethasone—multiple sclerosis	0.000541	0.00109	CcSEcCtD
Fosaprepitant—Stomatitis—Methotrexate—multiple sclerosis	0.000537	0.00108	CcSEcCtD
Fosaprepitant—Angiopathy—Prednisone—multiple sclerosis	0.000537	0.00108	CcSEcCtD
Fosaprepitant—Conjunctivitis—Methotrexate—multiple sclerosis	0.000536	0.00108	CcSEcCtD
Fosaprepitant—Immune system disorder—Prednisone—multiple sclerosis	0.000535	0.00108	CcSEcCtD
Fosaprepitant—Malaise—Betamethasone—multiple sclerosis	0.000534	0.00108	CcSEcCtD
Fosaprepitant—Malaise—Dexamethasone—multiple sclerosis	0.000534	0.00108	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000532	0.00107	CcSEcCtD
Fosaprepitant—Oedema—Triamcinolone—multiple sclerosis	0.000532	0.00107	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000531	0.00107	CcSEcCtD
Fosaprepitant—Syncope—Betamethasone—multiple sclerosis	0.000531	0.00107	CcSEcCtD
Fosaprepitant—Syncope—Dexamethasone—multiple sclerosis	0.000531	0.00107	CcSEcCtD
Fosaprepitant—Infection—Triamcinolone—multiple sclerosis	0.000529	0.00107	CcSEcCtD
Fosaprepitant—Infection—Methylprednisolone—multiple sclerosis	0.000528	0.00106	CcSEcCtD
Fosaprepitant—Haematuria—Methotrexate—multiple sclerosis	0.000525	0.00106	CcSEcCtD
Fosaprepitant—Shock—Triamcinolone—multiple sclerosis	0.000524	0.00106	CcSEcCtD
Fosaprepitant—Insomnia—Prednisolone—multiple sclerosis	0.000523	0.00106	CcSEcCtD
Fosaprepitant—Shock—Methylprednisolone—multiple sclerosis	0.000522	0.00105	CcSEcCtD
Fosaprepitant—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000521	0.00105	CcSEcCtD
Fosaprepitant—Loss of consciousness—Betamethasone—multiple sclerosis	0.00052	0.00105	CcSEcCtD
Fosaprepitant—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00052	0.00105	CcSEcCtD
Fosaprepitant—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00052	0.00105	CcSEcCtD
Fosaprepitant—Mental disorder—Prednisone—multiple sclerosis	0.000519	0.00105	CcSEcCtD
Fosaprepitant—Nausea—Azathioprine—multiple sclerosis	0.000518	0.00105	CcSEcCtD
Fosaprepitant—Skin disorder—Methylprednisolone—multiple sclerosis	0.000516	0.00104	CcSEcCtD
Fosaprepitant—Malnutrition—Prednisone—multiple sclerosis	0.000515	0.00104	CcSEcCtD
Fosaprepitant—Erythema—Prednisone—multiple sclerosis	0.000515	0.00104	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000515	0.00104	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000514	0.00247	CbGpPWpGaD
Fosaprepitant—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000513	0.00104	CcSEcCtD
Fosaprepitant—Hypertension—Dexamethasone—multiple sclerosis	0.000511	0.00103	CcSEcCtD
Fosaprepitant—Hypertension—Betamethasone—multiple sclerosis	0.000511	0.00103	CcSEcCtD
Fosaprepitant—Asthenia—Mitoxantrone—multiple sclerosis	0.000506	0.00102	CcSEcCtD
Fosaprepitant—Anxiety—Dexamethasone—multiple sclerosis	0.000502	0.00101	CcSEcCtD
Fosaprepitant—Anxiety—Betamethasone—multiple sclerosis	0.000502	0.00101	CcSEcCtD
Fosaprepitant—Discomfort—Dexamethasone—multiple sclerosis	0.000498	0.001	CcSEcCtD
Fosaprepitant—Discomfort—Betamethasone—multiple sclerosis	0.000498	0.001	CcSEcCtD
Fosaprepitant—Hypotension—Methylprednisolone—multiple sclerosis	0.000496	0.001	CcSEcCtD
Fosaprepitant—Pain—Prednisolone—multiple sclerosis	0.000495	0.000999	CcSEcCtD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000493	0.00238	CbGpPWpGaD
Fosaprepitant—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000489	0.000986	CcSEcCtD
Fosaprepitant—Urethral disorder—Methotrexate—multiple sclerosis	0.000485	0.000978	CcSEcCtD
Fosaprepitant—Oedema—Betamethasone—multiple sclerosis	0.000483	0.000974	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000483	0.000974	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000483	0.000974	CcSEcCtD
Fosaprepitant—Oedema—Dexamethasone—multiple sclerosis	0.000483	0.000974	CcSEcCtD
Fosaprepitant—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000483	0.000974	CcSEcCtD
Fosaprepitant—Insomnia—Triamcinolone—multiple sclerosis	0.000481	0.000971	CcSEcCtD
Fosaprepitant—Insomnia—Methylprednisolone—multiple sclerosis	0.00048	0.000969	CcSEcCtD
Fosaprepitant—Infection—Dexamethasone—multiple sclerosis	0.00048	0.000968	CcSEcCtD
Fosaprepitant—Infection—Betamethasone—multiple sclerosis	0.00048	0.000968	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Prednisone—multiple sclerosis	0.000478	0.000965	CcSEcCtD
Fosaprepitant—Feeling abnormal—Prednisolone—multiple sclerosis	0.000477	0.000962	CcSEcCtD
Fosaprepitant—Anaemia—Prednisone—multiple sclerosis	0.000476	0.000961	CcSEcCtD
Fosaprepitant—Shock—Betamethasone—multiple sclerosis	0.000475	0.000959	CcSEcCtD
Fosaprepitant—Shock—Dexamethasone—multiple sclerosis	0.000475	0.000959	CcSEcCtD
Fosaprepitant—Dyspnoea—Triamcinolone—multiple sclerosis	0.000475	0.000957	CcSEcCtD
Fosaprepitant—Nervous system disorder—Betamethasone—multiple sclerosis	0.000474	0.000956	CcSEcCtD
Fosaprepitant—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000474	0.000956	CcSEcCtD
Fosaprepitant—Angioedema—Prednisone—multiple sclerosis	0.000471	0.00095	CcSEcCtD
Fosaprepitant—Dyspepsia—Triamcinolone—multiple sclerosis	0.000469	0.000945	CcSEcCtD
Fosaprepitant—Erythema multiforme—Methotrexate—multiple sclerosis	0.000468	0.000944	CcSEcCtD
Fosaprepitant—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000467	0.000943	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000467	0.000942	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000467	0.000942	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CCL5—multiple sclerosis	0.000466	0.00225	CbGpPWpGaD
Fosaprepitant—Malaise—Prednisone—multiple sclerosis	0.000465	0.000938	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000463	0.00223	CbGpPWpGaD
Fosaprepitant—Eye disorder—Methotrexate—multiple sclerosis	0.000462	0.000933	CcSEcCtD
Fosaprepitant—Syncope—Prednisone—multiple sclerosis	0.000462	0.000932	CcSEcCtD
Fosaprepitant—Tinnitus—Methotrexate—multiple sclerosis	0.000461	0.000931	CcSEcCtD
Fosaprepitant—Urticaria—Prednisolone—multiple sclerosis	0.00046	0.000928	CcSEcCtD
Fosaprepitant—Cardiac disorder—Methotrexate—multiple sclerosis	0.000459	0.000926	CcSEcCtD
Fosaprepitant—Fatigue—Triamcinolone—multiple sclerosis	0.000459	0.000926	CcSEcCtD
Fosaprepitant—Fatigue—Methylprednisolone—multiple sclerosis	0.000458	0.000924	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000456	0.0022	CbGpPWpGaD
Fosaprepitant—Pain—Triamcinolone—multiple sclerosis	0.000455	0.000918	CcSEcCtD
Fosaprepitant—Loss of consciousness—Prednisone—multiple sclerosis	0.000453	0.000914	CcSEcCtD
Fosaprepitant—Hypotension—Betamethasone—multiple sclerosis	0.000451	0.00091	CcSEcCtD
Fosaprepitant—Hypotension—Dexamethasone—multiple sclerosis	0.000451	0.00091	CcSEcCtD
Fosaprepitant—Angiopathy—Methotrexate—multiple sclerosis	0.000449	0.000906	CcSEcCtD
Fosaprepitant—Vomiting—Mitoxantrone—multiple sclerosis	0.000449	0.000905	CcSEcCtD
Fosaprepitant—Immune system disorder—Methotrexate—multiple sclerosis	0.000447	0.000902	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000446	0.0009	CcSEcCtD
Fosaprepitant—Hypertension—Prednisone—multiple sclerosis	0.000445	0.000898	CcSEcCtD
Fosaprepitant—Rash—Mitoxantrone—multiple sclerosis	0.000445	0.000897	CcSEcCtD
Fosaprepitant—Dermatitis—Mitoxantrone—multiple sclerosis	0.000444	0.000897	CcSEcCtD
Fosaprepitant—Headache—Mitoxantrone—multiple sclerosis	0.000442	0.000892	CcSEcCtD
Fosaprepitant—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000439	0.000885	CcSEcCtD
Fosaprepitant—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000438	0.000883	CcSEcCtD
Fosaprepitant—Anxiety—Prednisone—multiple sclerosis	0.000437	0.000882	CcSEcCtD
Fosaprepitant—Insomnia—Dexamethasone—multiple sclerosis	0.000437	0.000881	CcSEcCtD
Fosaprepitant—Insomnia—Betamethasone—multiple sclerosis	0.000437	0.000881	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000436	0.000879	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000434	0.000876	CcSEcCtD
Fosaprepitant—Discomfort—Prednisone—multiple sclerosis	0.000433	0.000875	CcSEcCtD
Fosaprepitant—Mental disorder—Methotrexate—multiple sclerosis	0.000433	0.000874	CcSEcCtD
Fosaprepitant—Malnutrition—Methotrexate—multiple sclerosis	0.000431	0.000869	CcSEcCtD
Fosaprepitant—Erythema—Methotrexate—multiple sclerosis	0.000431	0.000869	CcSEcCtD
Fosaprepitant—Hypersensitivity—Prednisolone—multiple sclerosis	0.000426	0.00086	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CCL3—multiple sclerosis	0.000426	0.00205	CbGpPWpGaD
Fosaprepitant—Dyspepsia—Dexamethasone—multiple sclerosis	0.000425	0.000858	CcSEcCtD
Fosaprepitant—Dyspepsia—Betamethasone—multiple sclerosis	0.000425	0.000858	CcSEcCtD
Fosaprepitant—Urticaria—Triamcinolone—multiple sclerosis	0.000423	0.000853	CcSEcCtD
Fosaprepitant—Urticaria—Methylprednisolone—multiple sclerosis	0.000422	0.000851	CcSEcCtD
Fosaprepitant—Dysgeusia—Methotrexate—multiple sclerosis	0.000422	0.000851	CcSEcCtD
Fosaprepitant—Body temperature increased—Triamcinolone—multiple sclerosis	0.000421	0.000849	CcSEcCtD
Fosaprepitant—Oedema—Prednisone—multiple sclerosis	0.000421	0.000849	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Prednisone—multiple sclerosis	0.000421	0.000849	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CCR5—multiple sclerosis	0.00042	0.00202	CbGpPWpGaD
Fosaprepitant—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00042	0.000847	CcSEcCtD
Fosaprepitant—Decreased appetite—Dexamethasone—multiple sclerosis	0.00042	0.000847	CcSEcCtD
Fosaprepitant—Decreased appetite—Betamethasone—multiple sclerosis	0.00042	0.000847	CcSEcCtD
Fosaprepitant—Nausea—Mitoxantrone—multiple sclerosis	0.000419	0.000845	CcSEcCtD
Fosaprepitant—Infection—Prednisone—multiple sclerosis	0.000418	0.000843	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000417	0.000841	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000417	0.000841	CcSEcCtD
Fosaprepitant—Fatigue—Dexamethasone—multiple sclerosis	0.000416	0.00084	CcSEcCtD
Fosaprepitant—Fatigue—Betamethasone—multiple sclerosis	0.000416	0.00084	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000414	0.002	CbGpPWpGaD
Fosaprepitant—Shock—Prednisone—multiple sclerosis	0.000414	0.000835	CcSEcCtD
Fosaprepitant—Pain—Betamethasone—multiple sclerosis	0.000413	0.000833	CcSEcCtD
Fosaprepitant—Pain—Dexamethasone—multiple sclerosis	0.000413	0.000833	CcSEcCtD
Fosaprepitant—Nervous system disorder—Prednisone—multiple sclerosis	0.000412	0.000832	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—PTGER4—multiple sclerosis	0.00041	0.00198	CbGpPWpGaD
Fosaprepitant—Skin disorder—Prednisone—multiple sclerosis	0.000409	0.000824	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Prednisone—multiple sclerosis	0.000407	0.00082	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—PGR—multiple sclerosis	0.000404	0.00195	CbGpPWpGaD
Fosaprepitant—Ill-defined disorder—Methotrexate—multiple sclerosis	0.0004	0.000806	CcSEcCtD
Fosaprepitant—Anaemia—Methotrexate—multiple sclerosis	0.000398	0.000803	CcSEcCtD
Fosaprepitant—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000398	0.000803	CcSEcCtD
Fosaprepitant—Feeling abnormal—Betamethasone—multiple sclerosis	0.000398	0.000803	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CXCR3—multiple sclerosis	0.000396	0.00191	CbGpPWpGaD
Fosaprepitant—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000395	0.000797	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000395	0.000797	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CD28—multiple sclerosis	0.000392	0.00189	CbGpPWpGaD
Fosaprepitant—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000392	0.000791	CcSEcCtD
Fosaprepitant—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000391	0.000789	CcSEcCtD
Fosaprepitant—Malaise—Methotrexate—multiple sclerosis	0.000388	0.000784	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CCR2—multiple sclerosis	0.000385	0.00186	CbGpPWpGaD
Fosaprepitant—Urticaria—Betamethasone—multiple sclerosis	0.000384	0.000774	CcSEcCtD
Fosaprepitant—Urticaria—Dexamethasone—multiple sclerosis	0.000384	0.000774	CcSEcCtD
Fosaprepitant—Dizziness—Prednisolone—multiple sclerosis	0.000383	0.000772	CcSEcCtD
Fosaprepitant—Asthenia—Triamcinolone—multiple sclerosis	0.000382	0.00077	CcSEcCtD
Fosaprepitant—Abdominal pain—Betamethasone—multiple sclerosis	0.000382	0.00077	CcSEcCtD
Fosaprepitant—Abdominal pain—Dexamethasone—multiple sclerosis	0.000382	0.00077	CcSEcCtD
Fosaprepitant—Body temperature increased—Betamethasone—multiple sclerosis	0.000382	0.00077	CcSEcCtD
Fosaprepitant—Body temperature increased—Dexamethasone—multiple sclerosis	0.000382	0.00077	CcSEcCtD
Fosaprepitant—Asthenia—Methylprednisolone—multiple sclerosis	0.000381	0.000769	CcSEcCtD
Fosaprepitant—Insomnia—Prednisone—multiple sclerosis	0.00038	0.000767	CcSEcCtD
Fosaprepitant—Pruritus—Triamcinolone—multiple sclerosis	0.000377	0.00076	CcSEcCtD
Fosaprepitant—Cough—Methotrexate—multiple sclerosis	0.000376	0.000758	CcSEcCtD
Fosaprepitant—Pruritus—Methylprednisolone—multiple sclerosis	0.000376	0.000758	CcSEcCtD
Fosaprepitant—Dyspepsia—Prednisone—multiple sclerosis	0.00037	0.000747	CcSEcCtD
Fosaprepitant—Chest pain—Methotrexate—multiple sclerosis	0.000367	0.00074	CcSEcCtD
Fosaprepitant—Decreased appetite—Prednisone—multiple sclerosis	0.000366	0.000738	CcSEcCtD
Fosaprepitant—Rash—Prednisolone—multiple sclerosis	0.000365	0.000736	CcSEcCtD
Fosaprepitant—Dermatitis—Prednisolone—multiple sclerosis	0.000365	0.000736	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000364	0.000735	CcSEcCtD
Fosaprepitant—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000363	0.000733	CcSEcCtD
Fosaprepitant—Fatigue—Prednisone—multiple sclerosis	0.000363	0.000732	CcSEcCtD
Fosaprepitant—Headache—Prednisolone—multiple sclerosis	0.000363	0.000732	CcSEcCtD
Fosaprepitant—Discomfort—Methotrexate—multiple sclerosis	0.000362	0.000731	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—POMC—multiple sclerosis	0.000362	0.00174	CbGpPWpGaD
Fosaprepitant—Constipation—Prednisone—multiple sclerosis	0.00036	0.000726	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CNR1—multiple sclerosis	0.000355	0.00171	CbGpPWpGaD
Fosaprepitant—Dizziness—Triamcinolone—multiple sclerosis	0.000352	0.00071	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000351	0.000709	CcSEcCtD
Fosaprepitant—Dizziness—Methylprednisolone—multiple sclerosis	0.000351	0.000709	CcSEcCtD
Fosaprepitant—Infection—Methotrexate—multiple sclerosis	0.000349	0.000705	CcSEcCtD
Fosaprepitant—Feeling abnormal—Prednisone—multiple sclerosis	0.000347	0.000699	CcSEcCtD
Fosaprepitant—Asthenia—Dexamethasone—multiple sclerosis	0.000346	0.000699	CcSEcCtD
Fosaprepitant—Asthenia—Betamethasone—multiple sclerosis	0.000346	0.000699	CcSEcCtD
Fosaprepitant—Nervous system disorder—Methotrexate—multiple sclerosis	0.000345	0.000695	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000344	0.000694	CcSEcCtD
Fosaprepitant—Nausea—Prednisolone—multiple sclerosis	0.000344	0.000694	CcSEcCtD
Fosaprepitant—Pruritus—Betamethasone—multiple sclerosis	0.000342	0.000689	CcSEcCtD
Fosaprepitant—Pruritus—Dexamethasone—multiple sclerosis	0.000342	0.000689	CcSEcCtD
Fosaprepitant—Skin disorder—Methotrexate—multiple sclerosis	0.000341	0.000689	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00034	0.000686	CcSEcCtD
Fosaprepitant—Vomiting—Triamcinolone—multiple sclerosis	0.000338	0.000683	CcSEcCtD
Fosaprepitant—Vomiting—Methylprednisolone—multiple sclerosis	0.000338	0.000681	CcSEcCtD
Fosaprepitant—Rash—Triamcinolone—multiple sclerosis	0.000336	0.000677	CcSEcCtD
Fosaprepitant—Dermatitis—Triamcinolone—multiple sclerosis	0.000335	0.000676	CcSEcCtD
Fosaprepitant—Rash—Methylprednisolone—multiple sclerosis	0.000335	0.000676	CcSEcCtD
Fosaprepitant—Dermatitis—Methylprednisolone—multiple sclerosis	0.000335	0.000675	CcSEcCtD
Fosaprepitant—Urticaria—Prednisone—multiple sclerosis	0.000334	0.000674	CcSEcCtD
Fosaprepitant—Headache—Triamcinolone—multiple sclerosis	0.000333	0.000673	CcSEcCtD
Fosaprepitant—Headache—Methylprednisolone—multiple sclerosis	0.000333	0.000671	CcSEcCtD
Fosaprepitant—Body temperature increased—Prednisone—multiple sclerosis	0.000332	0.000671	CcSEcCtD
Fosaprepitant—Abdominal pain—Prednisone—multiple sclerosis	0.000332	0.000671	CcSEcCtD
Fosaprepitant—Diarrhoea—Dexamethasone—multiple sclerosis	0.00033	0.000667	CcSEcCtD
Fosaprepitant—Diarrhoea—Betamethasone—multiple sclerosis	0.00033	0.000667	CcSEcCtD
Fosaprepitant—Hypotension—Methotrexate—multiple sclerosis	0.000328	0.000663	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—POMC—multiple sclerosis	0.000328	0.00158	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCL2—multiple sclerosis	0.000321	0.00155	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCL10—multiple sclerosis	0.00032	0.00154	CbGpPWpGaD
Fosaprepitant—Dizziness—Betamethasone—multiple sclerosis	0.000319	0.000644	CcSEcCtD
Fosaprepitant—Dizziness—Dexamethasone—multiple sclerosis	0.000319	0.000644	CcSEcCtD
Fosaprepitant—Insomnia—Methotrexate—multiple sclerosis	0.000318	0.000641	CcSEcCtD
Fosaprepitant—Nausea—Triamcinolone—multiple sclerosis	0.000316	0.000638	CcSEcCtD
Fosaprepitant—Nausea—Methylprednisolone—multiple sclerosis	0.000315	0.000636	CcSEcCtD
Fosaprepitant—Dyspnoea—Methotrexate—multiple sclerosis	0.000313	0.000632	CcSEcCtD
Fosaprepitant—Somnolence—Methotrexate—multiple sclerosis	0.000312	0.00063	CcSEcCtD
Fosaprepitant—Hypersensitivity—Prednisone—multiple sclerosis	0.00031	0.000625	CcSEcCtD
Fosaprepitant—Dyspepsia—Methotrexate—multiple sclerosis	0.000309	0.000624	CcSEcCtD
Fosaprepitant—Vomiting—Dexamethasone—multiple sclerosis	0.000307	0.00062	CcSEcCtD
Fosaprepitant—Vomiting—Betamethasone—multiple sclerosis	0.000307	0.00062	CcSEcCtD
Fosaprepitant—Decreased appetite—Methotrexate—multiple sclerosis	0.000306	0.000616	CcSEcCtD
Fosaprepitant—Rash—Betamethasone—multiple sclerosis	0.000304	0.000614	CcSEcCtD
Fosaprepitant—Rash—Dexamethasone—multiple sclerosis	0.000304	0.000614	CcSEcCtD
Fosaprepitant—Dermatitis—Dexamethasone—multiple sclerosis	0.000304	0.000614	CcSEcCtD
Fosaprepitant—Dermatitis—Betamethasone—multiple sclerosis	0.000304	0.000614	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000303	0.000612	CcSEcCtD
Fosaprepitant—Fatigue—Methotrexate—multiple sclerosis	0.000303	0.000611	CcSEcCtD
Fosaprepitant—Headache—Betamethasone—multiple sclerosis	0.000303	0.00061	CcSEcCtD
Fosaprepitant—Headache—Dexamethasone—multiple sclerosis	0.000303	0.00061	CcSEcCtD
Fosaprepitant—Asthenia—Prednisone—multiple sclerosis	0.000302	0.000609	CcSEcCtD
Fosaprepitant—Pain—Methotrexate—multiple sclerosis	0.000301	0.000606	CcSEcCtD
Fosaprepitant—Pruritus—Prednisone—multiple sclerosis	0.000298	0.0006	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—TYK2—multiple sclerosis	0.000292	0.00141	CbGpPWpGaD
Fosaprepitant—Feeling abnormal—Methotrexate—multiple sclerosis	0.00029	0.000584	CcSEcCtD
Fosaprepitant—Diarrhoea—Prednisone—multiple sclerosis	0.000288	0.000581	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000287	0.00058	CcSEcCtD
Fosaprepitant—Nausea—Betamethasone—multiple sclerosis	0.000287	0.000579	CcSEcCtD
Fosaprepitant—Nausea—Dexamethasone—multiple sclerosis	0.000287	0.000579	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CD86—multiple sclerosis	0.00028	0.00135	CbGpPWpGaD
Fosaprepitant—Urticaria—Methotrexate—multiple sclerosis	0.000279	0.000563	CcSEcCtD
Fosaprepitant—Dizziness—Prednisone—multiple sclerosis	0.000278	0.000561	CcSEcCtD
Fosaprepitant—Abdominal pain—Methotrexate—multiple sclerosis	0.000278	0.000561	CcSEcCtD
Fosaprepitant—Body temperature increased—Methotrexate—multiple sclerosis	0.000278	0.000561	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CCL5—multiple sclerosis	0.000275	0.00133	CbGpPWpGaD
Fosaprepitant—Vomiting—Prednisone—multiple sclerosis	0.000267	0.00054	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—IL2—multiple sclerosis	0.000267	0.00129	CbGpPWpGaD
Fosaprepitant—Rash—Prednisone—multiple sclerosis	0.000265	0.000535	CcSEcCtD
Fosaprepitant—Dermatitis—Prednisone—multiple sclerosis	0.000265	0.000535	CcSEcCtD
Fosaprepitant—Headache—Prednisone—multiple sclerosis	0.000263	0.000532	CcSEcCtD
Fosaprepitant—Hypersensitivity—Methotrexate—multiple sclerosis	0.000259	0.000522	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—SPP1—multiple sclerosis	0.000255	0.00123	CbGpPWpGaD
Fosaprepitant—Asthenia—Methotrexate—multiple sclerosis	0.000252	0.000509	CcSEcCtD
Fosaprepitant—Nausea—Prednisone—multiple sclerosis	0.00025	0.000504	CcSEcCtD
Fosaprepitant—Pruritus—Methotrexate—multiple sclerosis	0.000249	0.000502	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CCR5—multiple sclerosis	0.000248	0.0012	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL2RA—multiple sclerosis	0.000245	0.00118	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IL2—multiple sclerosis	0.000243	0.00117	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Methotrexate—multiple sclerosis	0.00024	0.000485	CcSEcCtD
Fosaprepitant—Dizziness—Methotrexate—multiple sclerosis	0.000232	0.000469	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—APOE—multiple sclerosis	0.000226	0.00109	CbGpPWpGaD
Fosaprepitant—Vomiting—Methotrexate—multiple sclerosis	0.000223	0.000451	CcSEcCtD
Fosaprepitant—Rash—Methotrexate—multiple sclerosis	0.000222	0.000447	CcSEcCtD
Fosaprepitant—Dermatitis—Methotrexate—multiple sclerosis	0.000221	0.000447	CcSEcCtD
Fosaprepitant—Headache—Methotrexate—multiple sclerosis	0.00022	0.000444	CcSEcCtD
Fosaprepitant—Nausea—Methotrexate—multiple sclerosis	0.000209	0.000421	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—CD80—multiple sclerosis	0.000204	0.000984	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—POMC—multiple sclerosis	0.000194	0.000935	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCL2—multiple sclerosis	0.00019	0.000915	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000186	0.000895	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TYK2—multiple sclerosis	0.000172	0.00083	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL2—multiple sclerosis	0.000143	0.000691	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IL6—multiple sclerosis	0.000143	0.000688	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MMP9—multiple sclerosis	0.000136	0.000654	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—STAT3—multiple sclerosis	0.000121	0.000581	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MYC—multiple sclerosis	0.000112	0.00054	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TGFB1—multiple sclerosis	0.000112	0.000539	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MAPK1—multiple sclerosis	0.00011	0.000529	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL6—multiple sclerosis	8.43e-05	0.000406	CbGpPWpGaD
